巴西前瞻性出生队列中疫苗接种、学校出勤与营养对SARS-CoV-2抗体滴度的影响
研究基于2015年Pelotas(巴西)出生队列中2956名七岁儿童,采用线性回归模型分析COVID-19疫苗接种与抗体滴度的关联,并探讨该关联是否随营养状况和学校出勤时长变化。结果显示,接种疫苗儿童抗体滴度较未接种者高0.29光密度(OD)滴度单位(95%CI:0.24,0.34);每增加一个月学校注册时长,OD滴度增加0.15单位(95%CI:0.14,0.16)。在未接种儿童中,发育迟缓与较低的COVID-19滴度相关(-0.10,95%CI:-0.21,0.004),但在接种儿童中无此关联。
要点
- 接种疫苗儿童抗体滴度较未接种者高0.29 OD单位(95%CI:0.24,0.34)。
- 学校注册每增加一个月,抗体滴度增加0.15 OD单位(95%CI:0.14,0.16)。
- 发育迟缓与未接种儿童较低抗体滴度相关,接种后该关联消失。
核心结论
- 接种COVID-19疫苗与七岁儿童抗体滴度升高相关,学校出勤时长也与抗体滴度升高相关。
- 发育迟缓儿童可能对自然感染的免疫反应较差,但接种疫苗可克服这一缺陷。
- 作者认为,人群范围的后续疫苗接种可能有益,尤其在学校入学前及对发育迟缓儿童,以降低自然感染风险。
研究设计与样本
- 研究基于2015年Pelotas(巴西)出生队列,纳入2956名七岁儿童,采用线性回归模型分析疫苗接种与抗体滴度的关联,并检验营养状况和学校出勤时长的效应修饰。
主要发现
- 接种疫苗儿童较未接种儿童抗体滴度高0.29 OD滴度单位(95%CI:0.24,0.34)。
- 学校注册时长每增加一个月,OD滴度增加0.15单位(95%CI:0.14,0.16)。
- 在未接种儿童中,发育迟缓与较低的COVID-19抗体滴度相关(-0.10,95%CI:-0.21,0.004),但在接种儿童中无此关联。
临床怎么用
- 作者认为,人群范围的后续疫苗接种可能有益,尤其在学校入学前及对发育迟缓儿童,以降低自然感染风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In this study, we examine the association between COVID-19 vaccination and antibody titer and whether this association varies by nutritional status and duration of school attendance using linear regression models applied to seven-year-old children from the 2015 Pelotas (Brazil) Birth Cohort (n = 2956). Antibody titers were 0.29 optical density (OD) titer units higher among vaccinated compared with unvaccinated children (95 % CI: 0.24, 0.34). Duration of school enrollment was associated with increased antibody titer, with each month being associated with a 0.15 unit increase in OD titer (95 % CI: 0.14, 0.16). Stunting was associated with lower COVID-19 titers among unvaccinated children (-0.10, 95 % CI: -0.21,0.004), but not among vaccinated children. Stunted children may have poorer immune responses to natural infection, but vaccination can overcome this deficit. Population-wide follow-up vaccination may be beneficial, particularly prior to school entry and for stunted children to reduce the risk of natural infection.
引用
- Vahora MS, Leão O, da Silveira MF, et al. Impacts of vaccination, school attendance, and nutrition on SARS-CoV-2 antibody titer in a prospective birth cohort in Brazil. Vaccine. 2025. PMID: 39919488. doi:10.1016/j.vaccine.2025.126838
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。